Christoph Stoller is Teva’s Senior Vice President Generics and Commercial Operations Europe. He is also serving as Vice President of Medicines for Europe and leads Medicines for Europe’s sector group on Value Added Medicines. Christoph has been working for Teva Europe since 2011 after having joined Teva as General Manager in Switzerland in July 2008. Before joining Teva he worked for Zur Rose Group as member of the Executive Board and General Manager Helvepharm, DSM, F. Hoffmann-La Roche and Swiss Re. Christoph studied business administration at the University of St. Gallen, Switzerland.